Numeric Investors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Numeric Investors’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-7,280	Closed	-$109K	–	947
2014 Q1	$109K	Sell	7,280 -30	-0.4%	-$539	﹤0.01%	754
2013 Q4	$134K	Sell	7,310 -400	-5%	-$8.01K	﹤0.01%	744
2013 Q3	$159K	Sell	7,710 -1,790	-19%	-$41K	﹤0.01%	715
2013 Q2	$238K	Buy	+9,500	New	+$406K	﹤0.01%	703

Other funds holding AVEO

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

DVC

Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return

Numeric Investors's AVEO Position: Q2 2014 in Review

Numeric Investors sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2014, closing a stake of 7,280 shares — an estimated $109K sold.

Numeric Investors first reported a position in AVEO in Q2 2013 and held it in 4 quarters. The position peaked at $238K in Q2 2013. 61 funds tracked by Wall St. Rank hold AVEO as of Q2 2014.

Numeric Investors reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
Numeric Investors sold 7,280 AVEO Pharmaceuticals, Inc. shares in Q2 2014, an estimated $109K.
Numeric Investors first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 4 quarters.
Numeric Investors's AVEO Pharmaceuticals, Inc. position peaked at $238K in Q2 2013.
61 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2014.

Based on Numeric Investors's 13F filing for Q2 2014, filed 11 Aug 2014.